Literature DB >> 11561728

Analysis of matrix metalloproteinase mRNAs expressed in hepatocellular carcinoma cell lines.

J H Kim1, T H Kim, J W Jang, Y J Jang, K H Lee, S T Lee.   

Abstract

To analyze matrix metalloproteinase (MMP) mRNAs that are expressed in hepatocellular carcinoma cell lines, the kinds of MMP mRNAs were surveyed in HepG2 and Hep3B cells and normal liver by a reverse transcription-polymerase chain reaction using two degenerate primer pairs, derived from conserved domains of known MMPs. The level for each MMP mRNA was examined by Northern blot analysis in HepG2 and Hep3B cells, as well as in normal tissues. It was also examined by a reverse transcription-polymerase chain reaction analysis in 8 different hepatocellular carcinoma cell lines. MMP-2, MMP-14, and MMP-15 mRNAs were expressed at elevated levels in most of the cell lines studied, reflecting that these MMPs would play an important role in the invasion and metastasis of hepatocellular carcinoma. MMP-1, MMP-3, MMP-8, MMP-10, MMP-11, and MMP-13 mRNAs were also expressed in some or most of the cell lines. Interestingly, MMP-9 mRNA, as well as its polypeptide, was undetected in all of the cell lines studied. This implies that MMP-9, which was suggested as a tumor marker for hepatocellular carcinoma, would be expressed in stromal cells, rather than tumor cells. These results provide information for the basal levels of MMP mRNAs in various hepatocellular carcinoma cell lines. It will also facilitate study on the transcriptional regulation of each MMP mRNA by oncogenes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561728

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  8 in total

1.  The Contribution of Matrix Metalloproteinase-1 Genotypes to Hepatocellular Carcinoma Susceptibility in Taiwan.

Authors:  Yi-Liang Lai; Chi-Li Gong; Chun-Kai Fu; Te-Cheng Yueh; Chia-Wen Tsai; Wen-Shin Chang; Chieh-Lun Hsiao; Shiou-Ting Yen; Hsin-Ting Li; Long-Bin Jeng; Shou-Cheng Wang; DA-Tian Bau
Journal:  Cancer Genomics Proteomics       Date:  2017 Mar-Apr       Impact factor: 4.069

2.  Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics.

Authors:  Yan Li; Bo Tian; Jiong Yang; Lei Zhao; Xin Wu; Sheng-Long Ye; Yin-Kun Liu; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-05-14       Impact factor: 4.553

3.  Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines.

Authors:  Sung Hoon Choi; Hye Won Shin; Jun Yong Park; Ji Young Yoo; Do Young Kim; Weon Sang Ro; Chae-Ok Yun; Kwang-Hyub Han
Journal:  Korean J Hepatol       Date:  2010-09

4.  Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas.

Authors:  Marcin Nowak; Janusz A Madej; Bartosz Pula; Piotr Dziegiel; Rafal Ciaputa
Journal:  Ir Vet J       Date:  2016-08-02       Impact factor: 2.146

5.  Targeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply.

Authors:  Ken Liu; Xiang Zhang; Weiqi Xu; Jinbiao Chen; Jun Yu; Jennifer R Gamble; Geoffrey W McCaughan
Journal:  Clin Transl Gastroenterol       Date:  2017-06-15       Impact factor: 4.488

6.  The Role of MMP8 in Cancer: A Systematic Review.

Authors:  Krista Juurikka; Georgina S Butler; Tuula Salo; Pia Nyberg; Pirjo Åström
Journal:  Int J Mol Sci       Date:  2019-09-11       Impact factor: 5.923

7.  Activatable Peptides for Rapid and Simple Visualization of Protease Activity Secreted in Living Cells.

Authors:  Gae-Baik Kim; Jeong Min Lee; Duc Long Nguyen; Joonseok Lee; Young-Pil Kim
Journal:  Int J Mol Sci       Date:  2022-01-30       Impact factor: 5.923

Review 8.  Cleavable PEGylation: a strategy for overcoming the "PEG dilemma" in efficient drug delivery.

Authors:  Yan Fang; Jianxiu Xue; Shan Gao; Anqi Lu; Dongjuan Yang; Hong Jiang; Yang He; Kai Shi
Journal:  Drug Deliv       Date:  2017-12       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.